Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis
- PMID: 18360295
- DOI: 10.1097/MCG.0b013e318156617c
Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis
Abstract
Goals: To understand the relationship between acute recurrent pancreatitis and cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
Background: An emerging number of patients present with a nonclassic phenotype of cystic fibrosis (CF) with partial features or single-organ disease only. The association between the phenotype of recurrent pancreatitis CFTR dysfunction is unclear.
Methods: Patients with idiopathic recurrent pancreatitis were referred for electrophysiologic investigation.
Results: Thirty-three patients (18 males) aged 20+/-12 years with recurrent pancreatitis were studied. Three patients had mild asthma and 1 patient had mild ulcerative colitis. There was no family history of CF. All patients had normal imaging of the pancreatic duct by endoscopic retrograde cholangiopancreatography or magnetic resonance cholangiopancreatography. No patient was pancreatic insufficient. Mean sweat chloride values were 41+/-14 meq/L (range: 18 to 64). Nasal potential difference (NPD) measurement was pathologic in 7 patients. Mean basal potential difference in these 7 patients was -33+/-13 mV and there was an abnormal response to chloride-free and isoproterenol solutions. There was no difference in sweat chloride concentration between the 2 groups. Mutation analysis revealed W1282X/5T, D1152H/5T, and W1282X/- in 3 patients with abnormal NPD and 1 W1282X allele was found in 1 patient with normal NPD.
Conclusions: In this series, 21% of patients with recurrent pancreatitis have abnormalities of CFTR function. Patients presenting with recurrent, "idiopathic" pancreatitis require CFTR function testing.
Similar articles
-
Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.Am J Gastroenterol. 2004 Aug;99(8):1557-62. doi: 10.1111/j.1572-0241.2004.30834.x. Am J Gastroenterol. 2004. PMID: 15307877
-
Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.N Engl J Med. 1998 Sep 3;339(10):653-8. doi: 10.1056/NEJM199809033391002. N Engl J Med. 1998. PMID: 9725922
-
Association of pancreas divisum and recurrent acute pancreatitis with the IVS8-5T-12TG allele of the CFTR gene and CFTR dysfunction.Pancreas. 2007 Jul;35(1):90-3. doi: 10.1097/MPA.0b013e318054771f. Pancreas. 2007. PMID: 17575549
-
A novel exon duplication of the cystic fibrosis transmembrane conductance regulator in a patient presenting with adult-onset recurrent pancreatitis.Pancreas. 2011 Jul;40(5):773-7. doi: 10.1097/MPA.0b013e3182156e47. Pancreas. 2011. PMID: 21673536 Review.
-
The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.Eur J Gastroenterol Hepatol. 2008 Mar;20(3):157-60. doi: 10.1097/MEG.0b013e3282f36d16. Eur J Gastroenterol Hepatol. 2008. PMID: 18301292 Review.
Cited by
-
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation.PLoS One. 2013 Jul 26;8(7):e66955. doi: 10.1371/journal.pone.0066955. Print 2013. PLoS One. 2013. PMID: 23922647 Free PMC article. Clinical Trial.
-
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.BMC Pulm Med. 2014 Oct 4;14:156. doi: 10.1186/1471-2466-14-156. BMC Pulm Med. 2014. PMID: 25280757 Free PMC article.
-
Chronic pancreatitis in India and Asia.Curr Gastroenterol Rep. 2012 Apr;14(2):118-24. doi: 10.1007/s11894-012-0241-0. Curr Gastroenterol Rep. 2012. PMID: 22327961 Review.
-
Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.J Clin Invest. 2012 Oct;122(10):3755-68. doi: 10.1172/JCI60610. Epub 2012 Sep 17. J Clin Invest. 2012. PMID: 22996690 Free PMC article.
-
Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.J Cyst Fibros. 2014 Mar;13(2):139-47. doi: 10.1016/j.jcf.2013.09.007. J Cyst Fibros. 2014. PMID: 24660233 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical